Citadel Advisors’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Citadel Advisors’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-47,200	Closed	-$471K	–	15991
2022 Q3	$471K	Sell	47,200 -72,400	-61%	-$719K	﹤0.01%	8588
2022 Q2	$1.18M	Sell	119,600 -22,500	-16%	-$222K	﹤0.01%	6646
2022 Q1	$1.4M	Buy	142,100 +113,400	+395%	+$1.11M	﹤0.01%	6894
2021 Q4	$280K	Sell	28,700 -35,300	-55%	-$346K	﹤0.01%	11070
2021 Q3	$626K	Buy	64,000 +7,500	+13%	+$73.4K	﹤0.01%	9328
2021 Q2	$566K	Buy	56,500 +29,900	+112%	+$305K	﹤0.01%	9787
2021 Q1	$272K	Buy	+26,600	New	+$315K	﹤0.01%	11066

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's HAAC Position: Q3 2022 in Review

Citadel Advisors sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q3 2022, closing a stake of 51,200 shares — an estimated $509K sold.

Citadel Advisors first reported a position in HAAC in Q1 2021 and held it in 6 quarters. The position peaked at $1.97M in Q1 2021. 85 funds tracked by Wall St. Rank hold HAAC as of Q3 2022.

Citadel Advisors reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 51,200 Health Assurance Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $509K.
Citadel Advisors first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 6 quarters.
Citadel Advisors's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $1.97M in Q1 2021.
85 funds tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.